Newsroom
Newsroom
Industry News
With supply chain shortages at the forefront of nearly every business in the world right now, whether it be chicken wings or CAR-T cell therapy,...
Industry News
Fundraising at Bota Bio, Genomatica, and Antheia signals an upshift for commercial-scale synthetic biology......
Industry News
Antheia, a Menlo Park CA-based synthetic biology company, raised $73M in Series B funding. The round was led by Viking Global Investors with participation from...
Industry News
Antheia, a synthetic biology company working to develop plant-inspired medicine, has officially secured a fresh $73 million in Series B funding......
Industry News
Antheia, a synthetic biology company cofounded and led by Stanford University bioengineer Christina Smolke, has raised $73 million in series B financing......
Industry News
Antheia Inc., Menlo Park, $73 million: Viking Global Investors led the Series B funding of this company that's making plant-based medicines using synthetic biology. Sherpalo...
Industry News
On Thursday, the company announced it has completed its first commercial-scale fermentation run, which resulted in the production of 116,000liters of thebaine, a key ingredient...
Press Releases
Company's first full-scale fermentation run reinforces commercial viability for a robust pipeline of Biosynthetic KSMS and APIs...
Blog Posts
Antheia’s Chief Operations Officer Zack McGahey offers his perspective on the company’s most recent commercial milestone – a successful full-scale fermentation run of its first...
Blog Posts
As the newly appointed Senior Vice President of Commercialization, Richard Sherwin is poised to move Antheia into its next phase by building a vibrant commercial...
Industry News
With supply chain shortages at the forefront of nearly every business in the world right now, whether it be chicken wings or CAR-T cell therapy,...
Industry News
Fundraising at Bota Bio, Genomatica, and Antheia signals an upshift for commercial-scale synthetic biology......
Industry News
Antheia, a Menlo Park CA-based synthetic biology company, raised $73M in Series B funding. The round was led by Viking Global Investors with participation from...
Industry News
Antheia, a synthetic biology company working to develop plant-inspired medicine, has officially secured a fresh $73 million in Series B funding......
Industry News
Antheia, a synthetic biology company cofounded and led by Stanford University bioengineer Christina Smolke, has raised $73 million in series B financing......
Industry News
Antheia Inc., Menlo Park, $73 million: Viking Global Investors led the Series B funding of this company that's making plant-based medicines using synthetic biology. Sherpalo...
Blog Posts
Growth and change can be challenging within dynamic, evolving startups, but it’s easier to navigate when you are tuned in to how people experience the...
Blog Posts
Synthetic biology seems like a brand-new, precision scientific field – just bursting with potential – but is it really all that new? Biology is often...
Blog Posts
Technology today is defined by superlatives: we have the fastest cars, the best medicine, and the most advanced communication tools ever known. Yet despite humanity’s...
Blog Posts
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Heidi Pucel as its Chief People Officer. Pucel joins the company...
Blog Posts
Antheia is at a critical point in scaling our production technology. Just as we bring together exceptional science and technologies to unleash the power of...
Blog Posts
Synthetic biology isn’t a household name - yet. But it will be soon, because it’s a thriving, innovative field that’s solving some of humanity’s greatest...